Glucose and inflammation control islet vascular density and β-cell function in NOD mice control of islet vasculature and vascular endothelial growth factor by glucose

Diabetes

Volumn 60, Issue 3, 2011, Pages 876-883

  Akirav, Eitan M ^a   Baquero, Maria Teresa ^a   Opare Addo, Lynn W ^a   Akirav, Michael ^b   Galvan, Eva ^a   Kushner, Jake A ^c   Rimm, David L ^a   Herold, Kevan C ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BAR ILAN UNIVERSITY   (Israel)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; MONOCLONAL ANTIBODY CD3; PHLORIZIN; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DENSITY; CONTROLLED STUDY; DIABETES MELLITUS; ENDOTHELIUM CELL; FEMALE; GLUCOSE TOLERANCE; IMPAIRED GLUCOSE TOLERANCE; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET BETA CELL; PANCREATITIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; VASCULARIZATION;

ANIMALS; DIABETES MELLITUS, TYPE 1; FLUORESCENT ANTIBODY TECHNIQUE; GLUCOSE; INFLAMMATION; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; MICE; MICE, INBRED NOD; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79952378639     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db10-0793     Document Type: Article

References (33)

1. Sreenan S, Pick AJ, Levisetti M, Baldwin AC, Pugh W, Polonsky KS. Increased β-cell proliferation and reduced mass before diabetes onset in the nonobese diabetic mouse. Diabetes 1999;48:989-996 (Pubitemid 29226344)
2. Sherry NA, Kushner JA, Glandt M, Kitamura T, Brillantes AM, Herold KC. Effects of autoimmunity and immune therapy on β-cell turnover in type 1 diabetes. Diabetes 2006;55:3238-3245 (Pubitemid 44923579)
3. Akirav E, Kushner JA, Herold KC. β-Cell mass and type 1 diabetes: going, going, gone? Diabetes 2008;57:2883-2888
4. Dewitt LM. Morphology and physiology of areas of Langerhans in some vertebrates. J Exp Med 1906;8:193-239
5. Lai Y, Schneider D, Kidszun A, et al. Vascular endothelial growth factor increases functional beta-cell mass by improvement of angiogenesis of isolated human and murine pancreatic islets. Transplantation 2005;79:1530-1536 (Pubitemid 40847584)
6. Kamba T, Tam BY, Hashizume H, et al. VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature. Am J Physiol Heart Circ Physiol 2006;290:H560-H576
7. Brissova M, Shostak A, Shiota M, et al. Pancreatic islet production of vascular endothelial growth factor-a is essential for islet vascularization, revascularization, and function. Diabetes 2006;55:2974-2985 (Pubitemid 44923633)
8. Nyman LR, Ford E, Powers AC, Piston DW. Glucose-dependent blood flow dynamics in murine pancreatic islets in vivo. Am J Physiol Endocrinol Metab 2010;298:E807-E814
9. Savinov AY, Wong FS, Stonebraker AC, Chervonsky AV. Presentation of antigen by endothelial cells and chemoattraction are required for homing of insulin-specific CD8+ T cells. J Exp Med 2003;197:643-656 (Pubitemid 36314659)
10. Lozanoska-Ochser B, Klein NJ, Huang GC, Alvarez RA, Peakman M. Expression of CD86 on human islet endothelial cells facilitates T cell adhesion and migration. J Immunol 2008;181:6109-6116
11. Bone AJ, Walker R, Dean BM, Baird JD, Cooke A. Pre-diabetes in the spontaneously diabetic BB/E rat: pancreatic infiltration and islet cell proliferation. Acta Endocrinol (Copenh) 1987;115:447-454 (Pubitemid 17101071)
12. Bernard-Kargar C, Ktorza A. Endocrine pancreas plasticity under physiological and pathological conditions. Diabetes 2001;50(Suppl. 1):S30-S35 (Pubitemid 32148212)
13. Pechhold K, Koczwara K, Zhu X, et al. Blood glucose levels regulate pancreatic beta-cell proliferation during experimentally-induced and spontaneous autoimmune diabetes in mice. PLoS ONE 2009;4:e4827
14. Alonso LC, Yokoe T, Zhang P, et al. Glucose infusion in mice: a new model to induce β-cell replication. Diabetes 2007;56:1792-1801 (Pubitemid 47025447)
15. Rossetti L, Lauglin MR. Correction of chronic hyperglycemia with vanadate, but not with phlorizin, normalizes in vivo glycogen repletion and in vitro glycogen synthase activity in diabetic skeletal muscle. J Clin Invest 1989;84:892-899 (Pubitemid 19228361)
16. Collins TJ. ImageJ for microscopy. Biotechniques 2007;43(Suppl.):25-30
17. Camp RL, Chung GG, Rimm DL. Automated subcellular localization and quantification of protein expression in tissue microarrays. Nat Med 2002;8: 1323-1327 (Pubitemid 35373567)
18. Dolled-Filhart M, McCabe A, Giltnane J, Cregger M, Camp RL, Rimm DL. Quantitative in situ analysis of beta-catenin expression in breast cancer shows decreased expression is associated with poor outcome. Cancer Res 2006;66:5487-5494 (Pubitemid 43844977)
19. Gustavson MD, Bourke-Martin B, Reilly D, et al. Standardization of HER2 immunohistochemistry in breast cancer by automated quantitative analysis. Arch Pathol Lab Med 2009;133:1413-1419
20. Gould Rothberg BE, Berger AJ, Molinaro AM, et al. Melanoma prognostic model using tissue microarrays and genetic algorithms. J Clin Oncol 2009; 27:5772-5780
21. Moeder CB, Giltnane JM, Moulis SP, Rimm DL. Quantitative, fluorescence-based in-situ assessment of protein expression. Methods Mol Biol 2009;520: 163-175
22. McCabe A, Dolled-Filhart M, Camp RL, Rimm DL. Automated quantitative analysis (AQUA) of in situ protein expression, antibody concentration, and prognosis. J Natl Cancer Inst 2005;97:1808-1815 (Pubitemid 43033901)
23. Giltnane JM, Molinaro A, Cheng H, et al. Comparison of quantitative immunofluorescence with conventional methods for HER2/neu testing with respect to response to trastuzumab therapy in metastatic breast cancer. Arch Pathol Lab Med 2008;132:1635-1647
24. Eldor R, Yeffet A, Baum K, et al. Conditional and specific NF-kappaB blockade protects pancreatic beta cells from diabetogenic agents. Proc Natl Acad Sci USA 2006;103:5072-5077
25. Nikolova G, Lammert E. Interdependent development of blood vessels and organs. Cell Tissue Res 2003;314:33-42 (Pubitemid 37409911)
26. Jansson L, Carlsson PO. Graft vascular function after transplantation of pancreatic islets. Diabetologia 2002;45:749-763
27. Sherry NA, Chen W, Kushner JA, et al. Exendin-4 improves reversal of diabetes in NOD mice treated with anti-CD3 monoclonal antibody by enhancing recovery of beta-cells. Endocrinology 2007;148:5136-5144 (Pubitemid 350012634)
28. Campbell-Thompson M, Dixon LR, Wasserfall C, et al. Pancreatic adenocarcinoma patients with localised chronic severe pancreatitis show an increased number of single beta cells, without alterations in fractional insulin area. Diabetologia 2009;52:262-270
29. Baluk P, Yao LC, Feng J, et al. TNF-alpha drives remodeling of blood vessels and lymphatics in sustained airway inflammation in mice. J Clin Invest 2009;119:2954-2964
30. Mounzer RH, Svendsen OS, Baluk P, et al. Lymphotoxin-alpha contributes to lymphangiogenesis. Blood 2010;116:2173-2182
31. Sainson RC, Johnston DA, Chu HC, et al. TNF primes endothelial cells for angiogenic sprouting by inducing a tip cell phenotype. Blood 2008;111: 4997-5007
32. Hawinkels LJ, Zuidwijk K, Verspaget HW, et al. VEGF release by MMP-9 mediated heparan sulphate cleavage induces colorectal cancer angiogenesis. Eur J Cancer 2008;44:1904-1913
33. Bergers G, Brekken R, McMahon G, et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2000;2: 737-744